Abstract
Deep skin wounds represent a serious condition and frequently require split-thickness skin grafts (STSG) to heal. The application of autologous human-skin-cell-suspension (hSCS) requires less donor skin than STSG without compromising the healing capacity. Impaired function and replicative ability of senescent cutaneous cells in the aging skin affects healing with autologous hSCS. Major determinants of senescence are telomere erosion and DNA damage. Human telomerase reverse transcriptase (hTERT) adds telomeric repeats to the DNA and can protect against DNA damage. Herein, hTERT mRNA lipid nanoparticles (LNP) are proposed and evaluated for enhancing cellular engraftment and proliferation of hSCS. Transfection with optimized hTERT mRNA LNP system enables delivery and expression of mRNA in vitro in keratinocytes, fibroblasts, and in hSCS prepared from donors’ skin. Telomerase activity in hSCS is significantly increased. hTERT mRNA LNP enhance the generation of a partial-thickness human skin equivalent in the mouse model, increasing hSCS engraftment (Lamin) and proliferation (Ki67), while reducing cellular senescence (p21) and DNA damage (53BP1).
Original language | English (US) |
---|---|
Article number | 2302029 |
Pages (from-to) | e2302029 |
Journal | Advanced Healthcare Materials |
Volume | 13 |
Issue number | 2 |
Early online date | Aug 24 2023 |
DOIs | |
State | E-pub ahead of print - Aug 24 2023 |
Keywords
- lipid nanoparticles
- mRNA
- skin equivalence
- telomerase
- wound healing
ASJC Scopus subject areas
- Biomaterials
- Biomedical Engineering
- Pharmaceutical Science